Boston Scientific Corporation


Global medical device company focused on developing and commercializing therapies and technologies to treat a range of conditions including cancer and chronic pain. The company emphasizes product and patient safety, healthcare professional education, customer support, and corporate responsibility.

Industries

N/A

Nr. of Employees

small (1-50)

Boston Scientific Corporation


Products

Neuromodulation therapies (spinal cord stimulation)

Therapies using spinal cord stimulation technology for chronic pain relief demonstrated through patient cases.

Device-based cancer therapies

Therapeutic approaches and technologies aimed at reducing or removing tumors while minimizing side effects and pain.

E-commerce ordering and returns portal

Online ordering system for products and a managed process for product returns.


Services

Digital training and education delivered through a dedicated platform for healthcare professionals to access clinical education and training resources.

Customer-facing support services including representative contact channels, phone-based customer care, and returns processing.

Expertise Areas

  • Neuromodulation
  • Oncology therapies
  • Quality management and regulatory compliance
  • Healthcare professional education and training
  • Show More (4)

Key Technologies

  • Spinal cord stimulation (neuromodulation)
  • Device-based oncology therapies
  • Online learning management systems
  • E-commerce platforms
  • Show More (1)

News & Updates

Overview of three cancer therapies intended to destroy tumors, lessen side effects, and reduce pain.

Discussion of the company's approach to product quality and patient safety and the organizational culture supporting it.

Description of an internal career development program and employee stories.

Key takeaways from the company's recent quarterly financial results.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.